Barrack ER - Search Results

1

Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer.

Hakimi JM, Schoenberg MP, Rondinelli RH, Piantadosi S, Barrack ER. Hakimi JM, et al. Among authors: barrack er. Clin Cancer Res. 1997 Sep;3(9):1599-608. Clin Cancer Res. 1997. PMID: 9815849

2

Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancer.

Schoenberg MP, Hakimi JM, Wang S, Bova GS, Epstein JI, Fischbeck KH, Isaacs WB, Walsh PC, Barrack ER. Schoenberg MP, et al. Among authors: barrack er. Biochem Biophys Res Commun. 1994 Jan 14;198(1):74-80. doi: 10.1006/bbrc.1994.1011. Biochem Biophys Res Commun. 1994. PMID: 8292051 Free article.

3

Androgen-receptor gene structure and function in prostate cancer.

Hakimi JM, Rondinelli RH, Schoenberg MP, Barrack ER. Hakimi JM, et al. Among authors: barrack er. World J Urol. 1996;14(5):329-37. doi: 10.1007/BF00184606. World J Urol. 1996. PMID: 8912473 Review.

4

Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy.

Sadi MV, Walsh PC, Barrack ER. Sadi MV, et al. Among authors: barrack er. Cancer. 1991 Jun 15;67(12):3057-64. doi: 10.1002/1097-0142(19910615)67:12<3057::aid-cncr2820671221>3.0.co;2-s. Cancer. 1991. PMID: 1710537

5

Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Heterogeneity as a predictor of response to hormonal therapy.

Sadi MV, Barrack ER. Sadi MV, et al. Among authors: barrack er. Cancer. 1993 Apr 15;71(8):2574-80. doi: 10.1002/1097-0142(19930415)71:8<2574::aid-cncr2820710823>3.0.co;2-1. Cancer. 1993. PMID: 7680949

6

Androgen receptor mutations in prostate cancer.

Barrack ER. Barrack ER. Mt Sinai J Med. 1996 Oct-Nov;63(5-6):403-12. Mt Sinai J Med. 1996. PMID: 8898547 Review.

7

Determination of growth fraction in advanced prostate cancer by Ki-67 immunostaining and its relationship to the time to tumor progression after hormonal therapy.

Sadi MV, Barrack ER. Sadi MV, et al. Among authors: barrack er. Cancer. 1991 Jun 15;67(12):3065-71. doi: 10.1002/1097-0142(19910615)67:12<3065::aid-cncr2820671222>3.0.co;2-u. Cancer. 1991. PMID: 1710538

8

Androgen receptors and growth fraction in metastatic prostate cancer as predictors of time to tumour progression after hormonal therapy.

Sadi MV, Barrack ER. Sadi MV, et al. Among authors: barrack er. Cancer Surv. 1991;11:195-215. Cancer Surv. 1991. PMID: 1841752

9

Androgen receptor gene mutations in human prostate cancer.

Newmark JR, Hardy DO, Tonb DC, Carter BS, Epstein JI, Isaacs WB, Brown TR, Barrack ER. Newmark JR, et al. Among authors: barrack er. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6319-23. doi: 10.1073/pnas.89.14.6319. Proc Natl Acad Sci U S A. 1992. PMID: 1631125 Free PMC article.

10

A critical evaluation of the use of androgen receptor assays to predict the androgen responsiveness of prostatic cancer.

Barrack ER, Tindall DJ. Barrack ER, et al. Prog Clin Biol Res. 1987;239:155-87. Prog Clin Biol Res. 1987. PMID: 3309954 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters